By harnessing the power of publicly available and proprietary big biological data, deep learning and AI technologies, our core focus is to develop deep-tech solutions for Immuno-oncology.We have been developing a personalized immuno-oncology toolkit called Onco-cure. By analyzing tumour microenvironment (TME) dataset, Onco-Cure analytical dashboard is aiming at predicting patient specific immune biomarkers and allows oncologists to choose and develop the optimal targeted therapies for the patients. Mission of our proprietary Onco-Cure dashboard is to deliver most insightful approved targeted therapies to the oncologists, for their patients, within a timeframe of 48 hours.